BMY - Bristol Myers' Opdivo fails in Phase 3 lung cancer study
2024-05-10 17:13:16 ET
More on Bristol-Myers Squibb Company
- Bristol-Myers Squibb: A Lost Decade?
- Bristol Myers Squibb: Tough Times Continue
- Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript
- FDA accepts Bristol Myers application for injected Opdivo
- Pharma R&D productivity seen improving for the first time in years - Deloitte